Phase II Trial of RAD001 in Refractory Colorectal Cancer

NCT00337545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: RAD001

Sponsor

Swedish Medical Center

Collaborators

[object Object]